Psyched Wellness Ltd (CSE:PSYC) (OTCQB:PSYCF) (FRA:5U9), which is focused on the production and distribution of artisanal functional and psychedelic mushrooms, has appointed Amanda Galbraith to the board of directors to drive its communications strategy.
A trusted advisor to political leaders, CEOs, board directors, and executive teams, the company said Galbraith is one of Canada's foremost crisis communications and public affairs experts.
Galbraith is currently a principal at Navigator, Canada's leading high stakes public affairs firm, where she provides strategic counsel to private, public, and not-for-profit organizations, including those in the health, pharmaceutical, retail, finance, and technology sectors.
READ: Psyched Wellness says preclinical study showed no adverse effects from Amanita muscaria-derived products
Over the past 29 years, she has held senior communications roles with the Prime Minister of Canada and Mayor of Toronto and has also worked as a journalist. A regular media contributor, Galbraith is also the host of Free For All Friday, a weekly national radio show in the iHeartRadio talk network.
"I have had the opportunity to be at the centre of major political and regulatory decisions that have brought tremendous economic change and opportunity to the public throughout my career,” Galbraith said in a statement.
“The potential for functional and psychedelic mushrooms to address real health and wellness challenges underserviced by conventional medicine is transformative and something I am thrilled to be a part of. The product Psyched Wellness has begun to develop with Amanita shows tremendous promise, and I look forward to working with Jeff Stevens, the executive team, and the Board of Directors to move this product forward."
Psyched CEO Jeff Stevens added: "I am thrilled to welcome Amanda to our team as a Director on the Board. Amanda's wealth of experience in all things communications, coupled with her strong network of political and corporate contacts, will prove to be a great benefit to Psyched as we continue to move closer to commercialization of AME-1 derived consumer products."
In connection with Galbraith joining the board, the company said she will be issued 750,000 options, subject to board and exchange approvals. In addition to Galbraith's option issuance, 250,000 options will be allocated to a consultant.
Contact the author: patrick@proactiveinvestors.com
Follow him on Twitter @PatrickMGraham